| ncRNA name | LINC00152 |
| ncRNA Category | lncRNA |
| ID | 112597 |
| Ensembl | ENSG00000222041 |
| Synonyms | CYTOR; C2orf59; NCRNA00152 |
| Disease name | retinoblastoma (RB) |
| Species | Homo sapiens |
| Tissues/Cell_line | RB samples, normal retinas; RB cell lines Y79 and SO-RB50; RPE cell line ARPE-19 |
| Methods | transfection, qRT-PCR, CCK-8 assay, colony formation assay, apoptosis assay, wound healing assay, Western blot, xenograft |
| Expression pattern | up-regulated |
| Functional description | Knockdown of LINC00152 significantly inhibited cell proliferation, colony formation, migration, and invasion and promoted cell apoptosis and caspase-3 and caspase-8 activities in vitro, as well as suppressing tumorigenesis in vivo. |
| PubMed ID | 29922070 |
| Year | 2018 |
| Title | Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.